Moss David J 4
4 · Inmune Bio, Inc. · Filed Dec 2, 2025
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Moss David J
DirectorChief Executive Officer
Transactions
- Award
Option (right to buy)
2025-12-01+750,000→ 750,000 totalExercise: $1.48Exp: 2035-11-23→ Common Stock (750,000 underlying)
Footnotes (1)
- [F1]Granted pursuant to the Issuer's Second Amended and Restated 2021 Stock Incentive Plan. One-fourth (1/4) of the option will vest 12 months from the date of grant and thereafter the remaining unvested option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the date of grant.